CIK 0001671584
- Non-accelerated filer
- Smaller reporting company
Aptevo Therapeutics Inc.
Sign in to watch- Ticker
- APVO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 811567056
- Phone
- +1 206-838-0500
- Business address
- 2401 4TH AVE., SUITE 1050, SEATTLE, WA, 98121
- 4 Open-market buy Board of Directors bought 14,691 shares at $0.85 ($12,454)
- 4 Open-market buy Director bought 18,919 shares at $0.85 ($16,058)
- 4 Open-market buy Board of Directors bought 16,667 shares at $0.90 ($15,000)
- 4 Open-market buy President and CEO bought 50,000 shares at $0.88 ($44,000)
- 4 Open-market buy Board of Directors bought 10,000 shares at $0.85 ($8,481)
- 4 Open-market buy Board of Directors bought 50,000 shares at $0.78 ($39,000)
- 4 Open-market buy Senior VP, Operations bought 20,000 shares at $0.73 ($14,600)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Board of Directors bought 10,000 shares at $0.80 ($7,970)
- 4 Open-market buy President and CEO bought 30,000 shares at $0.81 ($24,300)
- 4 Open-market buy President and CEO bought 10,000 shares at $0.78 ($7,800)
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Chief Medical Officer and SVP gave up 4,823 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, GC and Corporate Affairs gave up 2,012 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
Page 9 of 14 · 265 filings